A national multicenter trial — Methotrexate on Effusion-synovitis and Symptoms in Knee Osteoarthritis (MESKO) (MESKO trial) — examining the use of methotrexate for inflammatory knee osteoarthritis (OA) has been published in JAMA Internal Medicine. It was condu...